GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 44 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,000 | +50.0% | 2,000 | +100.0% | 0.00% | – |
| Q3 2020 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +66.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | +50.0% | 1,000 | +100.0% | 0.00% | – |
| Q3 2019 | $2,000 | -81.8% | 500 | -66.7% | 0.00% | – |
| Q2 2019 | $11,000 | +37.5% | 1,500 | +47.5% | 0.00% | – |
| Q1 2019 | $8,000 | +700.0% | 1,017 | +959.4% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 96 | -79.1% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 460 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 460 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 460 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 460 | -7.6% | 0.00% | – |
| Q4 2015 | $4,000 | +33.3% | 498 | +8.3% | 0.00% | – |
| Q3 2015 | $3,000 | -40.0% | 460 | 0.0% | 0.00% | – |
| Q2 2015 | $5,000 | +25.0% | 460 | 0.0% | 0.00% | – |
| Q1 2015 | $4,000 | +33.3% | 460 | 0.0% | 0.00% | – |
| Q4 2014 | $3,000 | -25.0% | 460 | 0.0% | 0.00% | – |
| Q3 2014 | $4,000 | – | 460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,347,755 | $574,818 | 0.02% |
| Virtu Financial LLC | 31,633 | $13 | 0.00% |
| Western Wealth Management, LLC | 29,537 | $12,597 | 0.00% |
| Belpointe Asset Management LLC | 14,050 | $5,992 | 0.00% |
| TSFG, LLC | 3,000 | $1 | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 100 | $43 | 0.00% |
| Allworth Financial LP | 250 | $107 | 0.00% |
| JANE STREET GROUP, LLC | 13,189 | $5,625 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 138,040 | $58,874 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 500 | $214 | 0.00% |